Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center Identifier:
First received: October 25, 2005
Last updated: March 18, 2013
Last verified: March 2013